According to our (Global Info Research) latest study, the global Blood Analyser market size was valued at US$ 1388 million in 2025 and is forecast to a readjusted size of US$ 1852 million by 2032 with a CAGR of 4.2% during review period.
A Blood Analyser is an in-vitro diagnostic instrument used to automatically count, classify, test, and flag abnormalities in red blood cells, white blood cells, platelets, hemoglobin, and related hematological parameters from human whole blood samples. It is a core instrument for routine blood testing in hospital laboratories, independent clinical laboratories, health examination centers, and primary healthcare institutions. Typically using impedance, light scattering, fluorescence staining, flow-based detection, and intelligent algorithms, it analyzes cell counts, volume distribution, differential ratios, and abnormal signals. It supports three-part and five-part differentiation, reticulocyte testing, abnormal cell flagging, auto-review rules, and laboratory information system connectivity. Its clinical value lies in delivering fast, stable, and standardized results for infection, anemia, inflammation, bleeding risk, hematological disease screening, and treatment follow-up, making it one of the most widely adopted and clinically relied-upon instruments in modern laboratory medicine.In 2025, global Blood Analyser production reached approximately 111.93 k units and price is about 12.05 k USD/Unit.The average gross profit margin of this product is 45%.
Blood analysers represent one of the most fundamental, high-frequency, and demand-resilient segments within in-vitro diagnostic equipment. Market opportunities are driven by rising healthcare service volume, wider adoption of routine blood testing, laboratory automation upgrades, county-level healthcare capacity building, replacement of installed equipment, and high-end substitution by domestic brands. Complete blood count testing is an entry-level diagnostic item across outpatient, emergency, inpatient, preoperative assessment, infection screening, chronic disease management, oncology follow-up, and health examination scenarios, characterized by high testing frequency, broad patient coverage, and strong clinical dependence. For equipment manufacturers, blood analysers generate not only one-time instrument revenue, but also long-term customer value through reagent matching, quality control, maintenance, software connectivity, and total laboratory solutions, creating a stable installed-base ecosystem.Industry competition has evolved from traditional speed, parameter, and price competition into a broader contest involving accuracy, stability, abnormal sample recognition, anti-interference capability, auto-review rules, after-sales response, and integrated solution capability. High-end healthcare institutions require stronger performance in low platelet detection, abnormal white blood cell flagging, result consistency, automation-line compatibility, and information-system connectivity. Manufacturers must continue investing in core optics, precision fluidics, sensors, algorithms, and quality systems. The primary healthcare market has broad demand but remains price-sensitive, with procurement cycles influenced by budgets, tender policies, and equipment replacement schedules. Imported brands still retain brand inertia among premium customers, while domestic companies need to strengthen competitive barriers through clinical recognition, long-term reliability, and system integration capability.Downstream demand is showing a clear pattern of layered upgrading. Large hospitals focus on high throughput, reduced manual workload, intelligent validation, abnormal sample screening, digital morphology linkage, and laboratory automation connectivity. County hospitals and regional testing centers place greater emphasis on stability, cost-effectiveness, remote quality control, and ease of maintenance. Primary healthcare institutions require accessible instruments that are easy to operate, reliable in results, and low in training cost. Independent clinical laboratories pursue batch-processing efficiency, continuous operation, and optimized unit testing cost. In the future, blood analysers will evolve from standalone routine blood testing tools into key entry points for laboratory digitalization, regional diagnostic collaboration, and clinical data standardization.
This report is a detailed and comprehensive analysis for global Blood Analyser market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Analyser market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Blood Analyser market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Blood Analyser market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Blood Analyser market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Analyser
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Analyser market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sysmex Corporation, Danaher, Abbott Laboratories, Siemens Healthineers, HORIBA, Boule Diagnostics AB, Nihon Kohden, BioSystems, Diatron, Mindray Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Blood Analyser market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Three-part Differential
Five-part Differential
Market segment by Application Scenario
Clinical
Screening
Research
Other
Market segment by System Form
Benchtop
Floor-standing
Market segment by Application
Public Hospitals
Third-party Independent Laboratory
Other
Major players covered
Sysmex Corporation
Danaher
Abbott Laboratories
Siemens Healthineers
HORIBA
Boule Diagnostics AB
Nihon Kohden
BioSystems
Diatron
Mindray Medical
DYMIND
Urit Medical
Zybio
Dirui Medical
Maccura
Sinnowa
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blood Analyser product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Blood Analyser, with price, sales quantity, revenue, and global market share of Blood Analyser from 2021 to 2026.
Chapter 3, the Blood Analyser competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blood Analyser breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Blood Analyser market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Blood Analyser.
Chapter 14 and 15, to describe Blood Analyser sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Blood Analyser. Industry analysis & Market Report on Blood Analyser is a syndicated market report, published as Global Blood Analyser Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Blood Analyser market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.